Cipher Pharmaceuticals Inc. CPH.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · cipherpharma.com
Cipher Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused on acquiring, developing, and commercializing novel formulations of existing drugs for unmet medical needs. The company manages clinical development and regulatory approval processes and markets products directly in Canada or through partners in the U.S. and South America, with a focus on dermatology and hospital acute care therapeutics. Cipher is headquartered in Mississauga, Ontario, and has been operating since 2000.
Key ratios
CashFromOperationsYoYGrowth TTM 0.41
CashFromOperationsYoYGrowth 2025 0.52
CashFromOperationsYoYGrowth 2024 0.22
CashFromOperationsYoYGrowth 2023 0.49
DilutedEPSYoYGrowth TTM 2.28
DilutedEPSYoYGrowth 2025 1.28
DilutedEPSYoYGrowth 2024 -0.43
DilutedEPSYoYGrowth 2023 -0.22
FreeCashFlowOnSale TTM 0.59
FreeCashFlowOnSale 2025 0.59
FreeCashFlowOnSale 2024 -1.81
FreeCashFlowOnSale 2023 0.75
NetIncomeMargin TTM 0.61
NetIncomeMargin 2025 0.54
NetIncomeMargin 2024 0.35
NetIncomeMargin 2023 0.96
ReturnOnAssets TTM 0.08
ReturnOnAssets 2025 0.07
ReturnOnAssets 2024 0.04
ReturnOnAssets 2023 0.08
ReturnOnEquity TTM 0.26
ReturnOnEquity 2025 0.24
ReturnOnEquity 2024 0.13
ReturnOnEquity 2023 0.28
TotalRevenueYoYGrowth TTM 0.29
TotalRevenueYoYGrowth 2025 0.51
TotalRevenueYoYGrowth 2024 0.58
TotalRevenueYoYGrowth 2023 0.02
Recent news
Cipher Pharmaceuticals and the pan-Canadian Pharmaceutical Alliance (pCPA) Sign Letter of Intent for Public Drug Plan Coverage of Epuris
2026-07-06 · Newswire (CNW)
Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders
2026-06-18 · CNW (Canada Newswire)
Cipher Pharmaceuticals Reports First Quarter 2026 Results
2026-05-07 · CNW (Canada Newswire)
Cipher Pharmaceuticals Announces Normal Course Issuer Bid
2026-05-01 · CNW (Canada Newswire)
Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call
2026-04-29 · CNW (Canada Newswire)
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings
2026-03-12 · CNW (Canada Newswire)